Issuer Credit Research
Issuer Flash: ORIX Corporation – FY2026 Results
Issuer Flash: ORIX Corporation – FY2026 Results
Report date: 2026-05-12
Event date: 2026-05-11
Event title: FY2026 Results
1. Flash Conclusion
ORIX Corporation’s FY2026 results do not materially alter our existing credit view. Net income for the fiscal year ended March 2026 reached JPY 447.3 billion, delivering a ROE of 10.4% and slightly exceeding the full-year plan of JPY 440.0 billion. Shareholders’ equity stood at JPY 4.48 trillion, with a capital ratio of 24.9%, and cash and restricted cash totaled JPY 1.45 trillion, supporting the maintenance of an A rating for this diversified nonbank financial group.
However, the performance should not be interpreted solely as a "strong earnings" story. The year-on-year profit increase was significantly supported by gains related to Greenko, valuation gains on U.S. subsidiary fund investments, equity-method income, and asset sales. Investment segment profits of JPY 306.3 billion for FY2026 included JPY 95.0 billion from Greenko equity sales and valuation gains. The FY2027 net income guidance of JPY 530.0 billion also incorporates ORIX Bank sale gains of approximately JPY 124.2 billion and multiple private equity exits. Treating these one-off items as recurring earnings would be misleading.
In summary, the results are supportive in the short term, but the underlying credit characteristics remain unchanged. ORIX combines sticky earnings from insurance, corporate finance, and real asset operations with capital turnover returns from private equity, real estate, renewable energy, and overseas investments. Bond investors should focus on the discipline behind maintaining the A rating, capital allocation, impairments and credit costs at ORIX USA, and the pace of share buybacks throughout FY2027.
2. What Was Announced
| Metric | FY2025 / Mar-2025 | FY2026 / Mar-2026 | Credit Implications |
|---|---|---|---|
| Total Revenue | JPY 2,874.8 bn | JPY 3,330.8 bn | Revenue growth supported by life insurance, service income, and investment securities gains |
| Pre-Tax Profit | JPY 480.5 bn | JPY 691.4 bn | Up 44% YoY; driven by asset turnover gains and equity-method income |
| Net Income | JPY 351.6 bn | JPY 447.3 bn | Slightly above company plan of JPY 440.0 bn |
| ROE / Capital Ratio | 8.8% / 24.2% | 10.4% / 24.9% | Improved capital efficiency while maintaining capital strength |
| Total Assets / Equity | JPY 16.87 tn / JPY 4.09 tn | JPY 18.00 tn / JPY 4.48 tn | Capital accumulation keeps pace with asset growth |
| Interest-Bearing Debt / Deposits | JPY 6.28 tn / JPY 2.45 tn | JPY 6.54 tn / JPY 2.63 tn | Post-ORIX Bank sale composition requires monitoring |
For FY2027, the company announced guidance of JPY 530.0 billion net income, JPY 760.0 billion pre-tax profit, and ROE of 11.7%. The FY2026 dividend was JPY 156.10 per share, with FY2027 forecast at JPY 187.36. A share buyback program capped at JPY 250.0 billion was also approved, up from JPY 150.0 billion in FY2026, signaling a clearer focus on capital efficiency.
3. Credit Read-Through
-
Loss Absorption Capacity: The results reaffirm ORIX’s A-rated loss-absorbing capacity. Operating cash flow for FY2026 was JPY 1.37 trillion, ending cash and restricted cash totaled JPY 1.45 trillion, and shareholders’ equity was JPY 4.48 trillion. Capital remains robust despite dividends and share buybacks.
-
Quality of Earnings: Earnings quality should be discounted. Equity-method income rose 117% to JPY 123.9 billion, and gains on subsidiary and equity-method disposals amounted to JPY 111.3 billion. While this demonstrates ORIX’s value-creation and monetization capability, it is not recurring bank-like revenue. Credit analysis should emphasize base earnings excluding disposal gains and evaluate earnings resilience under weaker exit markets.
-
FY2027 Guidance and Shareholder Returns: These warrant a neutral to cautious monitoring stance. Maintenance of an A-level rating is explicitly stated, and expanded shareholder returns are not inherently negative. However, FY2027 guidance includes ORIX Bank sale gains of roughly JPY 124.2 billion, and combined dividend (39%) plus buybacks represents significant cash outflow. Flexibility in payout pace will be a key test if impairments or credit costs at ORIX USA spread.
-
ORIX Bank Sale: The transaction is neither strictly positive nor negative. The transfer price of JPY 370.0 billion and pre-tax gain of ~JPY 124.2 billion support capital efficiency and investment capacity, with JCR noting limited rating impact. Nonetheless, ORIX Bank was a stable subsidiary with total assets of ~JPY 3.1 trillion and net income of JPY 20.9 billion in FY2025. Post-sale, changes in deposits, bank assets, and regulatory capital composition mean FY2026-end deposits of JPY 2.63 trillion should not be interpreted as fully indicative of future funding stability.
-
ORIX USA: This remains the primary area of weakness. Segment profit fell to USD 95.4 million in FY2026, down 98% from USD 3.99 billion in the prior year. Drivers included goodwill and intangible asset impairments, higher SG&A, lower disposal gains, and increased credit costs. Assets rose 22% to USD 194 billion, underscoring the need to monitor post-acquisition integration and sensitivity to the U.S. credit environment.
4. What To Watch Next
- FY2027 base earnings excluding ORIX Bank sale gains, Toshiba/Kioxia-related items, private equity exits, and valuation gains.
- Pace of JPY 250.0 billion share buybacks, capital ratio trends, rating agency commentary, and consistency with A-rating policy.
- Post-ORIX Bank sale deposit, asset, liquidity, regulatory capital, and intra-group funding composition.
- Whether ORIX USA impairments and credit costs are transitory or indicative of underlying U.S. investment/operating profitability deterioration.
- Maturity profile, unused commitment lines, currency funding, and hybrid capital following FY2026 Form 20-F filing.
5. Sources
- ORIX,
Consolidated Financial Results April 1, 2025 - March 31, 2026, May 11, 2026.
https://www.orix.co.jp/grp/en/pdf/ir/library/financial_result/ORIXResults2026_4QE.pdf - ORIX,
Consolidated Financial Results Presentation for the Consolidated Fiscal Year Ended March 31, 2026, May 11, 2026.
https://www.orix.co.jp/grp/en/pdf/ir/library/presentation/Presentation_2026_4QE.pdf - ORIX,
Announcement Regarding Dividend for the Fiscal Year Ended March 31, 2026 and Annual Dividend Forecast for the Fiscal Year Ending March 31, 2027, May 11, 2026.
https://www.orix.co.jp/grp/en/newsrelease/pdf/260511_ORIXE.pdf - ORIX,
Notice Regarding Repurchase of Own Shares, May 11, 2026.
https://www.orix.co.jp/grp/en/newsrelease/pdf/260511_ORIXE2.pdf - ORIX,
Notice regarding Share Transfer of ORIX Bank Corporation, a Consolidated Subsidiary of ORIX Corporation, April 27, 2026.
https://www.orix.co.jp/grp/en/newsrelease/pdf/260427_ORIXE.pdf - JCR,
ORIX to Transfer Its Bank Subsidiary - Limited Impact on the Rating, April 28, 2026.
https://www.jcr.co.jp/en/ratinglist/finance/8591
6. Unverified / Pending
- FY2026 Form 20-F had not been confirmed at the time of this flash; detailed maturity profiles, unused commitment lines, currency funding, and individual security covenants as of March 2026 are not reflected.
- Post-results commentary or rating actions from R&I, Fitch, Moody's, and S&P have not been verified; only JCR’s April 28, 2026, comment on the ORIX Bank sale has been reviewed.
- Secondary market spreads, CDS, and relative value versus similarly rated nonbanks have not been verified.
- ORIX Bank sale completion is scheduled by October 2026; final transfer price, timing, and post-sale consolidated balance sheet impact remain undetermined.
- Impact on ORIX’s equity-method gains from partial sale of Kioxia shares by Toshiba is not reflected in FY2027 guidance and will be confirmed in the next earnings release.